ArticleBMC pregnancy and childbirth2026
Pregnant women's acceptability of intermittent preventive treatment with dihydroartemisinin-piperaquine from user and provider's perspectives: qualitative findings from the pilot implementation in Papua, Indonesia.
Article in BMC pregnancy and childbirth, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
introductionIntermittent preventive treatment with dihyroartemisinin-piperaquine (IPTp-DP) was found to be safe and more cost-effective than the current policy of single screening and treatment for the prevention of malaria in pregnancy in Papua, Indonesia. However, acceptability of the strategy under routine conditions has yet to be explored. This qualitative study explored pregnant women’s acceptability of IPTp-DP in the context of a Ministry of Health pilot programme.
methodsIn-depth interviews with 94 pregnant women, 103 healthcare providers/managers and 13 husbands were conducted at two time points in ten health centres as part of a wider mixed method evaluation of implementation feasibility. Data were coded using Sekhon’s Acceptability constructs. Thematic framework analysis was used to explore women’s acceptability of IPTp-DP over time and identify potential drivers of change, which were then triangulated with data from healthcare providers/managers and husbands.
resultsWomen perceived malaria in pregnancy to be a serious issue and valued the opportunity to prevent malaria with IPTp-DP. They had initial concerns about the safety of taking DP in pregnancy without a diagnostic test. Concerns about safety and side effects were allayed with information and reassurance from healthcare providers. Changes in women’s acceptability of IPTp-DP were mainly driven by improved communication about the intervention from providers and enhanced engagement with family members/husbands through quality improvement activities.
conclusionsHealth information about the benefits and safety of IPTp-DP for preventing malaria in pregnancy, together with support from spouses, were important drivers of women's acceptability of, and adherence to, IPTp-DP in this setting.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.